A recent analysis from a randomized clinical trial conducted by researchers at the Dana-Farber Brigham Cancer Center ...

A study finds that celecoxib improves disease-free survival in stage 3 colon cancer patients with positive ctDNA after ...

Natera has reported the latest data from the Phase III CALGB (Alliance)/SWOG 80702 study, indicating that Signatera, a ...

An analysis of ctDNA testing for early detection of recurrence showed that test had high sensitivity across multiple sites of ...